Spotlight on Psychiatry

Credits: 0.50 CME / CE
Research-based Clinical Strategies to Prevent and Address Adolescent Substance Use and Prescription Medication Misuse—Being Part of the Solution Part 1
Postgraduate Institute for Medicine

Research-based Clinical Strategies to Prevent and Address Adolescent Substance Use and Prescription Medication Misuse—Being Part of the Solution Part 1

Start

Activity Details

Free
AAFP, ACCME, ANCC, ADA

0.5 Credit

Released: June 29, 2017

Expires: June 27, 2019

30 minutes

No registration required

Target Audience

This activity had been designed to meet the educational needs of clinicians including, physicians, physician assistants, nurse practitioners, nurses, and dentists/oral maxillofacial surgeons, involved in the care of adolescent patients.

Learning Objectives

  • Describe the prevalence of substance use and prescription medication misuse among adolescents
  • Explain why adolescents are at high risk of developing a substance use disorder, and how clinicians can help to prevent it
  • Demonstrate strategies to build trust with adolescent patients, and ensure confidentiality when addressing substance use and prescription medication misuse

Activity Description

Videos from your peers enhance this course, which aims to help you navigate confidentiality and confidence in having effective discussions with your teen patients about their substance use. Features tips and talking points for patients at all risk levels, and considerations of prescription drug misuse. This course was developed by the Coalition of Healthcare Organizations and Providers to help clinicians identify, prevent, and address substance use and prescription medication misuse in their adolescent patients.

Instruction for Claiming Credit

A brief post-test and course evaluation will follow the completion of the course. Please complete these questionnaires to claim credit for this course.

Education Coalition

This activity was developed by an education Coalition of experts and medical professional organization representatives. The Coalition comprises the following organizations and experts:

Type of Reviewer:
Organization/Expert Consultant
Reviewer Name
California Academy of Family Physicians (CAFP) Cynthia Kear, Senior Vice President
American Society of Addiction Medicine (ASAM) Jennifer Butchart, Education Coordinator
Penny Mills, Executive Vice President / CEO
Arlene Deverman, VP Professional Development
American Osteopathic Association (AOA)

Stephanie Townsell, Director, Public Health
Marla Kushner, DO

American Association of Nurse Practitioners (AANP) Anne Norman, DNP, APRN, FNP-C, FAANP Vice President of Education and Accreditation
American Academy of Pediatrics (AAP) Renee Jarrett, Manager, Mental Health and Foster Care Initiatives
Div of Developmental Pediatrics and Preventive Services
American Academy of Physician Assistants (AAPA) Daniel Pace, Vice President, Education
Marie-Michele Leger, MPH, PA-C, Director, Clinical Education
Sara Evans, PMP, Project Manager, Quality Improvement Initiatives
American Association of Oral and Maxillofacial Surgeons (AAOMS) Vincent DiFabio, DDS
Consultant Samantha Mattiucci, PharmD, Director of Medical Education
Consultant Jan Schultz, BSN, MSN, RN, CCMEP, Director of Education Outcomes and Accreditation Services
Consultant Dan Alford, MD, Associate Professor of Medicine, Assistant Dean and Program Director of the Addiction Medicine Residency program at Boston University School of Medicine
Consultant Sharon Levy, MD, MPH, FAAP, Director, Adolescent Substance Abuse Program (ASAP) Assistant Professor in Pediatrics, Boston Children's Hospital
Consultant Jeff Baxter, MD, Assistant Professor
Department of Family Medicine and Community Health, University of Massachusetts Medical School
Consultant Marc Fishman, MD
Consultant Carol Havens, MD

Conflict of Interest Policy/ Disclosure Statement

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.  PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The Education Coalition members reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Marc Fishman, MD discloses the following: Consulting Fees: US World Meds; Contracted Research: Media Rez, US World Meds; Ownership Interest: Maryland Treatment Centers

The following Education Coalition members have nothing to disclose: Cynthia Kear, Jennifer Butchart, Penny Mills, Arlene Deverman, Stephanie Townsell, Marla Kushner, Anne Norman, Renee Jarrett, Daniel Pace, Marie-Michele Leger, Sara Evans, Vincent DiFabio, Jan Schultz, Dan Alford, Sharon Levy, Jeff Baxter, Marc Fishman, and Carol Havens

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following National Institute on Drug Abuse planners and managers, Elisabeth Davis; Carol Krause; Josie Anderson; Jack Stein, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

 The following JBS International, Inc. planners and managers, Candace Baker; Susan Hayashi; Laura Nolan; Bethel Arya; and Veronica Junghahn, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Physician Continuing Medical Education

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and the National Institute for Drug Abuse. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been reviewed and is acceptable for up to 1.00 Prescribed credit(s) by the American Academy of Family Physicians. AAFP certification begins 06/30/2017. Term of approval is for one year from this date.

This continuing medical education activity has been reviewed by the American Academy of Pediatrics and is acceptable for a maximum of 1.00 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the American Academy of Pediatrics.

Nursing Continuing Education

Credit Designation
This educational activity for 0.5 contact hour is provided by Postgraduate Institute for Medicine.

Accreditation Statement
Accreditation Council for Pharmacy EducationPostgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.


American Dental Association CERP Recognition

This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint sponsorship efforts between Postgraduate Institute for Medicine and the National Institute for Drug Abuse.

Postgraduate Institute for Medicine is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of the credit hours by boards of dentistry.

Postgraduate Institute for Medicine designates this activity for 0.5 continuing education credit.

Statement of Commercial Support

There is no commercial funding for this activity.

Media

Internet activity

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Hardware / Software Requirements

Pro-CME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari. Depending on your browser of choice, additional software, such as Adobe Reader® and Adobe® Flash® Player may be required.

Psychiatry Presentations

0.50 CME / CNE
AcademicCME
Non-Pharmacological Approaches to Managing Patients With Alzheimer’s Disease

Non-Pharmacological Approaches to Managing Patients With Alzheimer’s Disease

Start

Accredited By

Activity Details

Free CME/CNE
0.5 AMA PRA Category 1 Credits
0.5 CNE Contact Hours
Released: December 7, 2017
Expires: TBD
30 Minutes to complete

Target Audience

Neurologists, internists, nurse practitioners, and other healthcare professionals involved in the management of patients with Alzheimer’s disease.

Learning Objectives

  1. Evaluate non-pharmacological approaches for the treatment of AD
  2. Apply evidence-based data of non-pharmacological approaches to develop patient centered care

Activity Description

In this module of a Four-Part Expert Interview Series, Max Lugavere, along with Dr. Richard S. Isaacson, course chair, will explore non-pharmacological approaches to managing patients with Alzheimer’s disease (AD). Multi-modal intervention factors, including nutrition exercise, sleep hygiene and continued education, among others, will be reviewed, and best practices relayed. The faculty will also highlight recent clinical trial data regarding non-pharmacological methods of AD patient care. Clinical relevance of said data, both now and in the pipeline, will be deliberated. Following this educational activity, learners will have a better grasp of non-pharmacological intervention techniques as well as their potential impact in current and forthcoming AD patient care.

Statement of Educational Need

Health care team members need to manage all aspects of Alzheimer’s disease, including non-pharmacological, and understand how these factors affect the AD patient.

Agenda

Non-Pharmacological Approaches to Managing Patients With Alzheimer’s Disease

Faculty

Program Chair:
Richard S. Isaacson, MD

Associate Professor of Neurology
Director, Alzheimer’s Prevention Clinic
Weill Cornell Medicine
New York Presbyterian Hospital
New York, New York


Program Faculty:
Max Lugavere

Health and Science Journalist and Filmmaker
New York, New York


Disclosures of Conflict of Interest

It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity.


Faculty
Relationship Identified With:
Richard S. Isaacson, MD
Consultant/Advisor: Eli Lilly and Company; Neurotrack; 23 and Me
Max Lugavere
Nothing to disclose.

Non-faculty

Timothy Hayes, MD, PhD; Emma Boring; Nicole Brestowski, Chelsey Benedek and Kim Cheramie, MSN, RN-BC hereby state that neither they nor their spouse/life partner have any financial relationships to products or devices with any commercials interest related to the content of this activity of any amount during the past 12 months.

Accreditation Statement

AcademicCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AcademicCME is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation

Designation of Credit

AcademicCME designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AcademicCME designates this enduring material for a maximum of 0.5 CNE contact hours.

Instructions for Receiving Credit

  1. Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
  2. Complete the Pre-Activity Questions.
  3. Read or Review the activity content.
  4. Complete the Post-Activity Test Questions and Evaluation.
  5. Healthcare providers who receive a grade of 66% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a CME/CNE Certificate.
  6. All other participants who receive a grade of 66% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a Certificate of Participation.
  7. Healthcare providers should claim only the credit commensurate with the extent of their participation in the activity.
  8. 60 minutes of participation = 1 CNE contact hour

Statement of Commercial Support

This activity has been supported by an independent educational grant from Biogen.

Disclaimer Statement/Disclosure of Unlabeled Use

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information for Questions About the Activity

For all CME/CNE inquiries or special needs, please contact admin@academiccme.com.

Hardware/Software Requirements

Pro-CME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari. Depending on your browser of choice, additional software, such as Adobe Reader® and Adobe® Flash® Player may be required.

0.50 CME / CNE
AcademicCME
Clinical Trial Update: Therapeutic Strategies to Delay Disease Progression

Clinical Trial Update: Therapeutic Strategies to Delay Disease Progression

Start

Accredited By

Activity Details

Free CME/CNE
0.5 AMA PRA Category 1 Credits
0.5 CNE Contact Hours
Released: December 7, 2017
Expires: April 5, 2019
30 Minutes to complete

Target Audience

Neurologists, internists, nurse practitioners, and other healthcare professionals involved in the management of patients with Alzheimer’s disease.

Learning Objectives

  1. Analyze clinical trial data of emerging therapeutics to delay progression in the treatment of AD
  2. Implement shared decision making with the multidisciplinary team and patients/caregivers to develop individualized treatment plans and referral to clinical studies to advance treatment and improve the quality of life for patients with AD

Activity Description

In this module of a Four-Part Expert Interview Series, Dr. Marc E. Agronin, along with Dr. Richard S. Isaacson, course chair, will evaluate available therapeutic options for Alzheimer’s disease (AD) patient. The faculty will highlight the evolution of failed and existing therapies in AD, and their impact on current clinical care, emphasizing strategies for delaying disease progression in the modern day. Emerging therapies for the treatment and management of Alzheimer’s disease will also be assessed. Through completing this educational activity, learners will be better acquainted with emerging and emerged clinical trial data as it relates to AD care.

Statement of Educational Need

Health care team members need to be up-to-date on the most current strategies to delay disease progression in Alzheimer’s patients.

Agenda

Clinical Trial Update: Therapeutic Strategies to Delay Disease Progression

Faculty

Program Chair:
Richard S. Isaacson, MD

Associate Professor of Neurology
Director, Alzheimer’s Prevention Clinic
Weill Cornell Medicine
New York Presbyterian Hospital
New York, New York


Program Faculty:
Marc E. Agronin, MD

Vice President, Behavioral Health and Clinical Research
Miami Jewish Health
Affiliate Associate Professor of Psychiatry and Neurology
University of Miami Miller School of Medicine
Miami, Florida


Disclosures of Conflict of Interest

It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity.


Faculty
Relationship Identified With:
Richard S. Isaacson, MD
Consultant/Advisor: Eli Lilly and Company; Neurotrack; 23 and Me
Marc E. Agronin, MD
Consultant/Advisor: Eli Lilly and Company
Speaker's Bureau: Allergan

Non-faculty

Timothy Hayes, MD, PhD; Emma Boring; Nicole Brestowski, Chelsey Benedek and Kim Cheramie, MSN, RN-BC hereby state that neither they nor their spouse/life partner have any financial relationships to products or devices with any commercials interest related to the content of this activity of any amount during the past 12 months

Accreditation Statement

AcademicCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AcademicCME is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation

Designation of Credit

AcademicCME designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AcademicCME designates this enduring material for a maximum of 0.5 CNE contact hours.

Instructions for Receiving Credit

  1. Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
  2. Complete the Pre-Activity Questions.
  3. Read or Review the activity content.
  4. Complete the Post-Activity Test Questions and Evaluation.
  5. Healthcare providers who receive a grade of 66% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a CME/CNE Certificate.
  6. All other participants who receive a grade of 66% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a Certificate of Participation.
  7. Healthcare providers should claim only the credit commensurate with the extent of their participation in the activity.
  8. 60 minutes of participation = 1 CNE contact hour

Statement of Commercial Support

This activity has been supported by an independent educational grant from Biogen.

Disclaimer Statement/Disclosure of Unlabeled Use

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information for Questions About the Activity

For all CME/CNE inquiries or special needs, please contact admin@academiccme.com.

Hardware/Software Requirements

Pro-CME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari. Depending on your browser of choice, additional software, such as Adobe Reader® and Adobe® Flash® Player may be required.

0.50 CME / CNE
AcademicCME
The Role of Beta-Amyloid and Tau: CSF Protein Levels and PET Imaging

The Role of Beta-Amyloid and Tau: CSF Protein Levels and PET Imaging

Start

Accredited By

Activity Details

Free CME/CNE
0.5 AMA PRA Category 1 Credits
0.5 CNE Contact Hours
Released: December 7, 2017
Expires: TBD
30 Minutes to complete

Target Audience

Neurologists, internists, nurse practitioners, and other healthcare professionals involved in the management of patients with Alzheimer’s disease.

Learning Objectives

  1. Discuss recent developments in the diagnosis of AD such as the role of beta-amyloid and tau biomarkers
  2. Implement shared decision making with the patient and caregiver to develop individualized approach to diagnosis and treatment to improve the quality of life for patients with AD

Activity Description

In this module of a Four-Part Expert Interview Series, Dr. Barry W. Rovner, along with Dr. Richard S. Isaacson, course chair, will provide learners with an update regarding beta-amyloid and tau biomarkers and their role in Alzheimer’s disease (AD) pathology and progression. Recent guidelines and trial data relating to beta-amyloid and tau will be reviewed, and clinical relevance debated. Drs. Rovner and Isaacson will also discuss the diagnostic criteria for Alzheimer’s disease and intervention techniques for the various stages of disease. Upon completion of this educational activity, learners will be better equipped with best practices for managing beta amyloid and tau levels in practice to provide optimal care for patients with AD.

Statement of Educational Need

Health care team members need to understand the most recent clinical trial data regarding the treatment of AD patients, including beta-amyloid and tau biomarkers.

Agenda

The Role of Beta-Amyloid and Tau: CSF Protein Levels and PET Imaging

Faculty

Program Chair:
Richard S. Isaacson, MD

Associate Professor of Neurology
Director, Alzheimer’s Prevention Clinic
Weill Cornell Medicine
New York Presbyterian Hospital
New York, New York


Program Faculty:
Barry W. Rovner, MD

Professor, Departments of Neurology, Psychiatry, and Ophthalmology
Sidney Kimmel Medical College
Thomas Jefferson University
Jefferson Hospital for Neuroscience
Philadelphia, Pennsylvania


Disclosures of Conflict of Interest

It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity.


Faculty
Relationship Identified With:
Richard S. Isaacson, MD
Consultant/Advisor: Eli Lilly and Company; Neurotrack; 23 and Me
Barry W. Rovner, MD
Nothing to disclose.

Non-faculty

Timothy Hayes, MD, PhD; Emma Boring; Nicole Brestowski, Chelsey Benedek and Kim Cheramie, MSN, RN-BC hereby state that neither they nor their spouse/life partner have any financial relationships to products or devices with any commercials interest related to the content of this activity of any amount during the past 12 months

Accreditation Statement

AcademicCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AcademicCME is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation

Designation of Credit

AcademicCME designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AcademicCME designates this enduring material for a maximum of 0.5 CNE contact hours.

Instructions for Receiving Credit

  1. Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
  2. Complete the Pre-Activity Questions.
  3. Read or Review the activity content.
  4. Complete the Post-Activity Test Questions and Evaluation.
  5. Healthcare providers who receive a grade of 66% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a CME/CNE Certificate.
  6. All other participants who receive a grade of 66% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a Certificate of Participation.
  7. Healthcare providers should claim only the credit commensurate with the extent of their participation in the activity.
  8. 60 minutes of participation = 1 CNE contact hour

Statement of Commercial Support

This activity has been supported by an independent educational grant from Biogen.

Disclaimer Statement/Disclosure of Unlabeled Use

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information for Questions About the Activity

For all CME/CNE inquiries or special needs, please contact admin@academiccme.com.

Hardware/Software Requirements

Pro-CME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari. Depending on your browser of choice, additional software, such as Adobe Reader® and Adobe® Flash® Player may be required.

0.50 CME / CNE
AcademicCME
Early Diagnosis and Disease Monitoring: Pathology and Biomarkers

Early Diagnosis and Disease Monitoring: Pathology and Biomarkers

Start

Accredited By

Activity Details

Free CME/CNE
0.5 AMA PRA Category 1 Credits
0.5 CNE Contact Hours
Released: December 7, 2017
Expires: April 5, 2019
30 Minutes to complete

Target Audience

Neurologists, internists, nurse practitioners, and other healthcare professionals involved in the management of patients with Alzheimer’s disease.

Learning Objectives

  1. Review the pathology of Alzheimer’s disease, including disease monitoring and specific biomarkers for early diagnosis
  2. Identify the assessment and testing strategies for early diagnosis, monitoring, and personalized treatment of AD

Activity Description

In this module of a Four-Part Expert Interview Series, Max Lugavere, along with Dr. Richard S. Isaacson, course chair, will explore non-pharmacological approaches to managing patients with Alzheimer’s disease (AD). Multi-modal intervention factors, including nutrition exercise, sleep hygiene and continued education, among others, will be reviewed, and best practices relayed. The faculty will also highlight recent clinical trial data regarding non-pharmacological methods of AD patient care. Clinical relevance of said data, both now and in the pipeline, will be deliberated. Following this educational activity, learners will have a better grasp of non-pharmacological intervention techniques as well as their potential impact in current and forthcoming AD patient care.

Statement of Educational Need

Health care team members need to understand the pathology of Alzheimer’s disease in order to treat it most effectively, including the biomarkers for early diagnosis.

Agenda

Early Diagnosis and Disease Monitoring: Pathology and Biomarkers

Faculty

Program Chair:
Richard S. Isaacson, MD

Associate Professor of Neurology
Director, Alzheimer’s Prevention Clinic
Weill Cornell Medicine
New York Presbyterian Hospital
New York, New York


Program Faculty:
James E. Galvin, MD, MPH

Professor and Associate Dean for Clinical Research
Director, Comprehensive Center for Brain Health
Charles E. Schmidt College of Medicine
Florida Atlantic University
Boca Raton, Florida


Disclosures of Conflict of Interest

It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity.


Faculty
Relationship Identified With:
Richard S. Isaacson, MD
Consultant/Advisor: Eli Lilly and Company; Neurotrack; 23 and Me
James E. Galvin, MD, MPH
Nothing to disclose.

Non-faculty

Timothy Hayes, MD, PhD; Emma Boring; Nicole Brestowski, Chelsey Benedek and Kim Cheramie, MSN, RN-BC hereby state that neither they nor their spouse/life partner have any financial relationships to products or devices with any commercials interest related to the content of this activity of any amount during the past 12 months.

Accreditation Statement

AcademicCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AcademicCME is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation

Designation of Credit

AcademicCME designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AcademicCME designates this enduring material for a maximum of 0.5 CNE contact hours.

Instructions for Receiving Credit

  1. Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
  2. Complete the Pre-Activity Questions.
  3. Read or Review the activity content.
  4. Complete the Post-Activity Test Questions and Evaluation.
  5. Healthcare providers who receive a grade of 66% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a CME/CNE Certificate.
  6. All other participants who receive a grade of 66% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a Certificate of Participation.
  7. Healthcare providers should claim only the credit commensurate with the extent of their participation in the activity.
  8. 60 minutes of participation = 1 CNE contact hour

Statement of Commercial Support

This activity has been supported by an independent educational grant from Biogen.

Disclaimer Statement/Disclosure of Unlabeled Use

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information for Questions About the Activity

For all CME/CNE inquiries or special needs, please contact admin@academiccme.com.

Hardware/Software Requirements

Pro-CME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari. Depending on your browser of choice, additional software, such as Adobe Reader® and Adobe® Flash® Player may be required.

0.50 CME / CE
Postgraduate Institute for Medicine
Research-based Clinical Strategies to Prevent and Address Adolescent Substance Use and Prescription Medication Misuse—Being Part of the Solution Part 2

Research-based Clinical Strategies to Prevent and Address Adolescent Substance Use and Prescription Medication Misuse—Being Part of the Solution Part 2

Start

Activity Details

Free
AAFP, ACCME, ANCC, ADA

0.5 Credit

Released: June 29, 2017

Expires: June 27, 2019

30 minutes

No registration required

Target Audience

This activity had been designed to meet the educational needs of clinicians including, physicians, physician assistants, nurse practitioners, nurses, and dentists/oral maxillofacial surgeons, involved in the care of adolescent patients.

Learning Objectives

  • Discuss strategies to address substance use and prescription drug misuse in adolescent patients based on their level of use
  • Summarize when and how to follow up with adolescent patients who use substances or misuse prescription drugs

Activity Description

Videos from your peers enhance this course, which aims to help you navigate confidentiality and confidence in having effective discussions with your teen patients about their substance use. Features tips and talking points for patients at all risk levels, and considerations prescription drug misuse. This course was developed by a Coalition Healthcare Organizations and Providers to help clinicians identify, prevent, and address substance use and prescription medication misuse in their adolescent patients.

Instruction for Claiming Credit

A brief post-test and course evaluation will follow the completion of the course. Please complete these questionnaires to claim credit for this course.

Education Coalition

This activity was developed by an education Coalition of experts and medical professional organization representatives. The Coalition comprises the following organizations and experts:

Type of Reviewer:
Organization/Expert Consultant
Reviewer Name
California Academy of Family Physicians (CAFP) Cynthia Kear, Senior Vice President
American Society of Addiction Medicine (ASAM) Jennifer Butchart, Education Coordinator
Penny Mills, Executive Vice President / CEO
Arlene Deverman, VP Professional Development
American Osteopathic Association (AOA)

Stephanie Townsell, Director, Public Health
Marla Kushner, DO

American Association of Nurse Practitioners (AANP) Anne Norman, DNP, APRN, FNP-C, FAANP Vice President of Education and Accreditation
American Academy of Pediatrics (AAP) Renee Jarrett, Manager, Mental Health and Foster Care Initiatives
Div of Developmental Pediatrics and Preventive Services
American Academy of Physician Assistants (AAPA) Daniel Pace, Vice President, Education
Marie-Michele Leger, MPH, PA-C, Director, Clinical Education
Sara Evans, PMP, Project Manager, Quality Improvement Initiatives
American Association of Oral and Maxillofacial Surgeons (AAOMS) Vincent DiFabio, DDS
Consultant Samantha Mattiucci, PharmD, Director of Medical Education
Consultant Jan Schultz, BSN, MSN, RN, CCMEP, Director of Education Outcomes and Accreditation Services
Consultant Dan Alford, MD, Associate Professor of Medicine, Assistant Dean and Program Director of the Addiction Medicine Residency program at Boston University School of Medicine
Consultant Sharon Levy, MD, MPH, FAAP, Director, Adolescent Substance Abuse Program (ASAP) Assistant Professor in Pediatrics, Boston Children's Hospital
Consultant Jeff Baxter, MD, Assistant Professor
Department of Family Medicine and Community Health, University of Massachusetts Medical School
Consultant Marc Fishman, MD
Consultant Carol Havens, MD

Conflict of Interest Policy/ Disclosure Statement

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.  PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The Education Coalition members reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Marc Fishman, MD discloses the following: Consulting Fees: US World Meds; Contracted Research: Media Rez, US World Meds; Ownership Interest: Maryland Treatment Centers

The following Education Coalition members have nothing to disclose: Cynthia Kear, Jennifer Butchart, Penny Mills, Arlene Deverman, Stephanie Townsell, Marla Kushner, Anne Norman, Renee Jarrett, Daniel Pace, Marie-Michele Leger, Sara Evans, Vincent DiFabio, Jan Schultz, Dan Alford, Sharon Levy, Jeff Baxter, Marc Fishman, and Carol Havens

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following National Institute on Drug Abuse planners and managers, Elisabeth Davis; Carol Krause; Josie Anderson; Jack Stein, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

 The following JBS International, Inc. planners and managers, Candace Baker; Susan Hayashi; Laura Nolan; Bethel Arya; and Veronica Junghahn, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Physician Continuing Medical Education

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and the National Institute for Drug Abuse. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been reviewed and is acceptable for up to 1.00 Prescribed credit(s) by the American Academy of Family Physicians. AAFP certification begins 06/30/2017. Term of approval is for one year from this date.

This continuing medical education activity has been reviewed by the American Academy of Pediatrics and is acceptable for a maximum of 1.00 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the American Academy of Pediatrics.

Nursing Continuing Education

Credit Designation
This educational activity for 0.5 contact hour is provided by Postgraduate Institute for Medicine.

Accreditation Statement
Accreditation Council for Pharmacy EducationPostgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.


American Dental Association CERP Recognition

This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint sponsorship efforts between Postgraduate Institute for Medicine and the National Institute for Drug Abuse.

Postgraduate Institute for Medicine is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of the credit hours by boards of dentistry.

Postgraduate Institute for Medicine designates this activity for 0.5 continuing education credit.

Statement of Commercial Support

There is no commercial funding for this activity.

Media

Internet activity

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Hardware / Software Requirements

Pro-CME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari. Depending on your browser of choice, additional software, such as Adobe Reader® and Adobe® Flash® Player may be required.

0.50 CME / CE
Postgraduate Institute for Medicine
Research-based Clinical Strategies to Prevent and Address Adolescent Substance Use and Prescription Medication Misuse—Being Part of the Solution Part 1

Research-based Clinical Strategies to Prevent and Address Adolescent Substance Use and Prescription Medication Misuse—Being Part of the Solution Part 1

Start

Activity Details

Free
AAFP, ACCME, ANCC, ADA

0.5 Credit

Released: June 29, 2017

Expires: June 27, 2019

30 minutes

No registration required

Target Audience

This activity had been designed to meet the educational needs of clinicians including, physicians, physician assistants, nurse practitioners, nurses, and dentists/oral maxillofacial surgeons, involved in the care of adolescent patients.

Learning Objectives

  • Describe the prevalence of substance use and prescription medication misuse among adolescents
  • Explain why adolescents are at high risk of developing a substance use disorder, and how clinicians can help to prevent it
  • Demonstrate strategies to build trust with adolescent patients, and ensure confidentiality when addressing substance use and prescription medication misuse

Activity Description

Videos from your peers enhance this course, which aims to help you navigate confidentiality and confidence in having effective discussions with your teen patients about their substance use. Features tips and talking points for patients at all risk levels, and considerations of prescription drug misuse. This course was developed by the Coalition of Healthcare Organizations and Providers to help clinicians identify, prevent, and address substance use and prescription medication misuse in their adolescent patients.

Instruction for Claiming Credit

A brief post-test and course evaluation will follow the completion of the course. Please complete these questionnaires to claim credit for this course.

Education Coalition

This activity was developed by an education Coalition of experts and medical professional organization representatives. The Coalition comprises the following organizations and experts:

Type of Reviewer:
Organization/Expert Consultant
Reviewer Name
California Academy of Family Physicians (CAFP) Cynthia Kear, Senior Vice President
American Society of Addiction Medicine (ASAM) Jennifer Butchart, Education Coordinator
Penny Mills, Executive Vice President / CEO
Arlene Deverman, VP Professional Development
American Osteopathic Association (AOA)

Stephanie Townsell, Director, Public Health
Marla Kushner, DO

American Association of Nurse Practitioners (AANP) Anne Norman, DNP, APRN, FNP-C, FAANP Vice President of Education and Accreditation
American Academy of Pediatrics (AAP) Renee Jarrett, Manager, Mental Health and Foster Care Initiatives
Div of Developmental Pediatrics and Preventive Services
American Academy of Physician Assistants (AAPA) Daniel Pace, Vice President, Education
Marie-Michele Leger, MPH, PA-C, Director, Clinical Education
Sara Evans, PMP, Project Manager, Quality Improvement Initiatives
American Association of Oral and Maxillofacial Surgeons (AAOMS) Vincent DiFabio, DDS
Consultant Samantha Mattiucci, PharmD, Director of Medical Education
Consultant Jan Schultz, BSN, MSN, RN, CCMEP, Director of Education Outcomes and Accreditation Services
Consultant Dan Alford, MD, Associate Professor of Medicine, Assistant Dean and Program Director of the Addiction Medicine Residency program at Boston University School of Medicine
Consultant Sharon Levy, MD, MPH, FAAP, Director, Adolescent Substance Abuse Program (ASAP) Assistant Professor in Pediatrics, Boston Children's Hospital
Consultant Jeff Baxter, MD, Assistant Professor
Department of Family Medicine and Community Health, University of Massachusetts Medical School
Consultant Marc Fishman, MD
Consultant Carol Havens, MD

Conflict of Interest Policy/ Disclosure Statement

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.  PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The Education Coalition members reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Marc Fishman, MD discloses the following: Consulting Fees: US World Meds; Contracted Research: Media Rez, US World Meds; Ownership Interest: Maryland Treatment Centers

The following Education Coalition members have nothing to disclose: Cynthia Kear, Jennifer Butchart, Penny Mills, Arlene Deverman, Stephanie Townsell, Marla Kushner, Anne Norman, Renee Jarrett, Daniel Pace, Marie-Michele Leger, Sara Evans, Vincent DiFabio, Jan Schultz, Dan Alford, Sharon Levy, Jeff Baxter, Marc Fishman, and Carol Havens

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following National Institute on Drug Abuse planners and managers, Elisabeth Davis; Carol Krause; Josie Anderson; Jack Stein, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

 The following JBS International, Inc. planners and managers, Candace Baker; Susan Hayashi; Laura Nolan; Bethel Arya; and Veronica Junghahn, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Physician Continuing Medical Education

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and the National Institute for Drug Abuse. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been reviewed and is acceptable for up to 1.00 Prescribed credit(s) by the American Academy of Family Physicians. AAFP certification begins 06/30/2017. Term of approval is for one year from this date.

This continuing medical education activity has been reviewed by the American Academy of Pediatrics and is acceptable for a maximum of 1.00 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the American Academy of Pediatrics.

Nursing Continuing Education

Credit Designation
This educational activity for 0.5 contact hour is provided by Postgraduate Institute for Medicine.

Accreditation Statement
Accreditation Council for Pharmacy EducationPostgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.


American Dental Association CERP Recognition

This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint sponsorship efforts between Postgraduate Institute for Medicine and the National Institute for Drug Abuse.

Postgraduate Institute for Medicine is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of the credit hours by boards of dentistry.

Postgraduate Institute for Medicine designates this activity for 0.5 continuing education credit.

Statement of Commercial Support

There is no commercial funding for this activity.

Media

Internet activity

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Hardware / Software Requirements

Pro-CME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari. Depending on your browser of choice, additional software, such as Adobe Reader® and Adobe® Flash® Player may be required.